Vimizim™ is a trademark, and BioMarin ®, Naglazyme ®, Kuvan ® and Firdapse™ are registered trademarks of BioMarin Pharmaceutical Inc.

Aldurazyme ® is a registered trademark of BioMarin/Genzyme LLC.
CONTACT: Investors:         Eugenia Shen         BioMarin Pharmaceutical Inc.         (415) 506-6570                  Media:         Debra Charlesworth         BioMarin Pharmaceutical Inc         (415) 455-7451

BioMarin Pharmaceutical Inc. Logo

If you liked this article you might like

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Trump's FDA: A Friendlier Biotech Sheriff

Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run

Why I Hate the FAANGs (but Like Banks and Biotech) for 2017's Second Half

3 Fearless Predictions for the Second Half